| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr4_0090400 | Intergenic-Intergenic | chr4:121605186-121606730 | chr4:120684031-120685575 | 1545 nt | 0.3074 |
| hsa_PRDM5_0001200 | Intergenic-Exon | chr4:121606075-121631568 | chr4:120684920-120710413 | 211 nt | 0.4313 |
| hsa_PRDM5_0000800 | Intergenic-Intron | chr4:121606075-121677297 | chr4:120684920-120756142 | 250 nt | 0.3120 |
| hsa_PRDM5_0001300 | Intergenic-Exon | chr4:121606075-121706246 | chr4:120684920-120785091 | 94 nt | 0.4362 |
| hsa_PRDM5_0001400 | Intergenic-Exon | chr4:121606075-121720900 | chr4:120684920-120799745 | 179 nt | 0.3799 |
| hsa_PRDM5_0001500 | Intergenic-Exon | chr4:121606075-121732604 | chr4:120684920-120811449 | 271 nt | 0.3321 |
| hsa_PRDM5_0000900 | Intergenic-Exon | chr4:121606075-121737729 | chr4:120684920-120816574 | 250 nt | 0.3480 |
| hsa_PRDM5_0001000 | Intergenic-Exon | chr4:121606075-121742472 | chr4:120684920-120821317 | 250 nt | 0.3000 |
| hsa_PRDM5_0001100 | Intergenic-Exon | chr4:121606075-121742500 | chr4:120684920-120821345 | 250 nt | 0.3040 |
| hsa_chr4_0090500 | Intergenic-Intergenic | chr4:121606395-121606730 | chr4:120685240-120685575 | 336 nt | 0.2976 |
A study in humans demonstrated that serum levels of circPRDM5 were significantly decreased in acute myocardial infarction (AMI) patients compared to healthy controls and angina patients, with an area under the receiver operating characteristic curve of 0.862 [Liu et al. DOI:10.1016/j.gene.2024.148142].